SBFM

18.22% -0.41

Dopo l'orario di chiusura: 1.92 0.08 +4.35%

Sunshine Biopharma Inc (SBFM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Sunshine Biopharma Inc

Healthcare (1177)

954-515-0810

333 LAS OLAS WAY, FORT LAUDERDALE

Prossima data di guadagno

Ultimi documenti SEC

SBFM's Discussions on Twitter

Confronta SBFM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SBFM Sunshine Biopharma Inc	1.84	4.98M	32.96M	-4.23M	-14.00M	-155.33
ZTS Zoetis Inc	159.61	71.47B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.19	47.98B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.45	47.20B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	14.85	17.02B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	307.36	13.80B	2.76B	1.11B	898.10M	22.77

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Sunshine Biopharma Inc (SBFM)

Sunshine Biopharma Inc Stock (SBFM) Company Profile

Confronta SBFM con altri titoli

Sunshine Biopharma Inc Borsa (SBFM) Ultime notizie

Sunshine Biopharma Secures $2.46 Million in Direct Offering - TipRanks

Sunshine Biopharma Closes $2.5 Million Direct Offering - MarketScreener

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering - ACCESS Newswire

Sunshine Biopharma Raises Fresh Capital: $2.46M from Institutional Investors - Stock Titan

SEC Form 424B5 filed by Sunshine Biopharma Inc. - Quantisnow

Sunshine Biopharma stock hits 52-week low at $1.85 amid steep decline - Investing.com India

Sunshine Biopharma’s K1.1-mRNA-LNP shows promise in HCC mouse model - BioWorld MedTech

The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM) - Sete News

Sunshine Biopharma Reports 78% Revenue Growth and Key Developments in 2022 - TipRanks

Sunshine Biopharma (SBFM) Secures $2.46 Million in Direct Stock Offering - GuruFocus

Sunshine Biopharma secures $2.46 million in stock offering - Investing.com

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - ACCESS Newswire

$2.46M Institutional Investment: Sunshine Biopharma Announces Strategic Direct Offering - Stock Titan

Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug - Benzinga

Biotech Stock Sunshine Biopharma Inc. (NASDAQ:SBFM) Makes NASDAQ Top Gainer List on News - Investorideas.com

Sunshine Biopharma (SBFM) Announces Promising Results for Liver Cancer Treatment - GuruFocus

Sunshine Biopharma reports progress in liver cancer treatment - Investing.com India

Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell - MarketScreener

Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews

Revolutionary mRNA Treatment Succeeds Against Deadly Liver Cancer in Latest Trial - Stock Titan

Sunshine Biopharma (SBFM) Reports Increased Revenue Despite Net Loss - GuruFocus

Sunshine Biopharma (SBFM) Reports 2024 Financial Highlights - GuruFocus

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year - ACCESS Newswire

Sunshine Biopharma Reports Record Revenue: 13 New Drugs and Cancer Treatment Breakthrough - Stock Titan

Sunshine Biopharma Inc. SEC 10-K Report - TradingView

Sunshine Biopharma (SBFM) Stock Soars In Pre-Market Trading - Stocks Telegraph

Sunshine Biopharma Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView

Sunshine Biopharma signs agreement for rights to market two generic antibiotics - Yahoo Finance

Sunshine Biopharma to market new antibiotics in Canada By Investing.com - Investing.com Australia

Sunshine Biopharma acquires marketing rights for two new antibiotics in Canada - MSN

Sunshine Biopharma to market new antibiotics in Canada - Investing.com India

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada - Yahoo Finance

Major Antibiotics Deal: Sunshine Biopharma Expands Portfolio in Billion-Dollar Market - Stock Titan

Sunshine Biopharma stock hits 52-week low at $2.01 By Investing.com - Investing.com Australia

Sunshine Biopharma stock hits 52-week low at $2.01 - Investing.com India

Sunshine Biopharma (NASDAQ:SBFMW) Trading Down 0.5% – Should You Sell? - Defense World

Sunshine Biopharma expands with new gastrointestinal drug By Investing.com - Investing.com Canada

Sunshine Biopharma expands with new gastrointestinal drug - Investing.com India

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market - ACCESS Newswire

Sunshine Biopharma stock hits 52-week low at $2.09 By Investing.com - Investing.com Australia

Sunshine Biopharma stock hits 52-week low at $2.09 - Investing.com India

A Look at Sunshine Biopharma Inc (SBFM) Shares in the Recent Past Indicates Growth - SETE News

Sunshine Biopharma (NASDAQ:SBFMW) Trading 30% Higher – Should You Buy? - Defense World

Sunshine Biopharma Announces Reverse Stock Split - ACCESS Newswire

Sunshine Biopharma Launches Two New Generic Prescription Drugs - ACCESS Newswire

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) - ACCESS Newswire

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - ACCESS Newswire

Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga

Who’s Hired? Haruvi Returns For A Second Term As AAM Chair - News & Insights

Sunshine Biopharma launches Olanzapine and Olanzapine ODT - Indian Pharma Post

Sunshine Biopharma introduces new generic drugs in Canada - MSN

Sunshine Biopharma Inc Azioni (SBFM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SBFM